This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Aromatase Inhibitor

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Aromatase Inhibitors Are and How They Work

Aromatase inhibitors, often called AI drugs, are medicines that lower estrogen levels in the body by blocking an enzyme named aromatase. Aromatase helps the body produce estrogen, especially in the ovaries and other tissues like fat. Since some breast cancers need estrogen to grow, lowering estrogen can slow or stop these cancer cells from growing. Common AI drugs include anastrozole, letrozole, and exemestane.

Why Aromatase Inhibitors Matter in Breast Cancer Care

Many breast cancers have hormone receptors, meaning they grow in response to hormones like estrogen. When cancer cells have these receptors, lowering estrogen can reduce the chance that the cancer will grow or come back. Aromatase inhibitors are mainly used in postmenopausal women because, after menopause, the ovaries produce less estrogen and the body relies more on aromatase to make estrogen in other tissues. For premenopausal women, AI drugs may be combined with treatments that suppress ovarian function to lower estrogen effectively.

When and Where You Might Hear About Aromatase Inhibitors

You might hear the term aromatase inhibitor during conversations with your doctor, nurse, or pharmacist. It could also appear in your medical records, treatment plans, or information about clinical trials. Hearing about AI drugs means your care team is considering hormone therapy as part of your treatment plan. However, it does not automatically mean your cancer is advanced or that hormone therapy is the only treatment you will receive.

How Doctors Use Aromatase Inhibitors in Treatment Planning

Doctors test tumor samples to see if cancer cells have hormone receptors, such as estrogen or progesterone receptors. If the cancer is hormone receptor positive, AI drugs might be recommended after surgery, chemotherapy, or radiation to reduce the chance of cancer returning. The choice to use these drugs depends on factors like menopausal status, cancer stage, and overall treatment goals. AI drugs can be used alone or with other treatments depending on your situation.

Common Confusions and Important Clarifications

Many people find the term AI drug confusing because it sounds like it might relate to artificial intelligence. In cancer care, AI stands for aromatase inhibitor. These drugs work by blocking aromatase, which helps the body make estrogen. This is different from other hormone therapies like tamoxifen, which block estrogen receptors on cancer cells rather than lowering estrogen levels. Understanding this difference can help you follow your treatment plan better.

Questions to Ask Your Care Team

If aromatase inhibitors are part of your treatment, it can help to ask your care team why this therapy is recommended for you, how it works with other treatments you’re receiving, what side effects to watch for, and if there are lifestyle changes that can support your therapy. These questions can help you understand your treatment and manage your health during therapy.

Understanding the Term in Context and Next Steps

Sources

Public source information used for this glossary entry includes: